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Abstract
We report here a rare case of undifferentiated carcinoma
of the pancreas mimicking main-duct intraductal papil-
lary mucinous neoplasm. In an 80-year-old woman, an
approximately 8-mm papillary mass was incidentally
detected at the downstream edge of a dilatated main
pancreatic duct lumen on CT and MRI. Main pancreatic
duct dilatation in the pancreatic body and tail and
parenchymal atrophy were observed in the upstream of
the mass. Histopathologically, the tumor protruded into
the downstream edge of the dilatated main pancreatic
duct lumen in the pancreatic body. The tumor cells had
highly atypical nuclei and abundant polymorphic struc-
tures, and showed positive staining for granulocyte col-
ony-stimulating factor, which led to the diagnosis of
undifferentiated carcinoma. A total of 13 cases of
undifferentiated carcinoma with intraductal tumor
growth have been reported to date. The case report by
Bergmann et al. has been the smallest in histopatholo-
gical specimen, and the present case is the smallest in size
detected by radiological images. Since early undifferen-
tiated carcinoma of the pancreas can resemble those of
main-duct intraductal papillary mucinous neoplasm in
cross-sectional images, we have to consider undifferen-
tiated carcinoma in the differential diagnosis of the sol-
itary and papillary mass with low contrast enhancement
in early phase in the main pancreatic duct.
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Undifferentiated carcinoma of the pancreas is a subtype of
pancreatic ductal carcinoma [1]. In general, the tumor size is
large at onset and many cases have wide-spread hematog-
enous metastasis and lymphogenous metastasis, which
result in an unfavorable prognosis [2]. We experienced a
rare case of undifferentiated carcinoma of the pancreas
mimicking main-duct intraductal papillary mucinous neo-
plasm (IPMN), in that the tumor was small and showed
intraductal growth into the main pancreatic duct on imag-
ing.Histopathological finding of this casewas interesting in
the histogenesis of undifferentiated carcinoma. Herein, we
report our case with discussion about differential diagnosis
of the papillary mass in the main pancreatic duct.
Case report
An 80-year-old woman underwent a medical examina-
tion for hematuria, and a left renal pelvic tumor was
detected on computed tomography (CT). Meanwhile, a
mass was incidentally found in the pancreatic body, and
a close examination was conducted. Her past medical
history was colon cancer (endoscopically resected),
uterine leiomyoma, appendicitis, and hypertension, but
her family history was unremarkable. In the laboratory
examination, the white blood cell (WBC) count and tu-
mor markers (carcinoembryonic antigen, carbohydrate
antigen 19-9, and pancreatic cancer-associated antigen)
were within the normal limits.Correspondence to: Yuichi Kawai; email: i4pt18sw@yk.commufa.jp
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On CT, the main pancreatic duct was dilatated to
12 mm in largest diameter in the pancreatic body and
tail, and an approximately 8-mm papillary mass was
observed at the downstream edge of the dilatated duct
lumen. The mass showed slight enhancement between the
pancreatic phase and delayed phase on dynamic CT and
its border with the surrounding parenchyma was irreg-
ular. The pancreatic parenchyma in the body and tail
Fig. 1. A–E Axial pre-enhanced (A) and axial multiphase
dynamic contrast-enhanced (B pancreatic phase; C portal
venous phase; D equilibrium phase) and coronal contrast-
enhanced (E portal venous phase) CT images show a papil-
lary mass at the downstream edge of the dilatated main
pancreatic duct lumen (arrows). The mass is slightly
enhanced between the pancreatic phase and delayed phase
on a dynamic study. The duct is dilatated in the pancreatic
body and tail, but not in the downstream of the mass. The
surrounding pancreatic parenchyma in the body and tail is
atrophic and its border with the mass is irregular.
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showed atrophy, with prolonged contrast enhancement.
Main pancreatic duct dilatation was not seen in the
downstream of the mass (Fig. 1). On magnetic resonance
imaging, magnetic resonance cholangiopancreatography
(MRCP) showed main pancreatic duct dilatation in the
body and tail with a low signal intensity papillary mass in
the downstream edge of the dilatated duct lumen. Main
pancreatic duct dilatation in the downstream of the mass
was not observed (Fig. 2). The 18F-fluorodeoxyglucose-
positron emission tomography combined with computed
tomography (18F-FDG-PET/CT) showed uptake of
FDG in accord with the papillary mass in the pancreatic
body. That increased in the delayed phase (maximum
standardized uptake value (SUVmax): 4.4) compared
with the early phase (SUVmax: 3.2) (Fig. 3).
Main-duct IPMN with an associated invasive carci-
noma was suspected on the grounds that the dilated main
pancreatic duct accompanied a solidary nodule, and
distal pancreatectomy was performed. Meanwhile,
left nephrectomy was performed for the left renal pelvic
tumor.
In the loupe ﬁndings, the tumor protruded papillary
into the downstream edge of the dilatated main pancre-
atic duct lumen in the pancreatic body. The maximum
diameter of the papillate region of the tumor was 8 mm
and the region of interstitial inﬁltrate was 7 mm. The
entire epithelium of the main pancreatic duct was
substituted by atypical cells. Histopathologically, the
tumor cells had highly atypical nuclei and abundant
scattered polymorphic structures, and numerous multi-
nucleated giant cells were also observed. The tumor cells
showed positive staining for granulocyte colony-stimu-
lating factor (G-CSF) (Fig. 4). The pathological diag-
nosis was undifferentiated carcinoma (pleomorphic
type). The tumor slightly invaded the surrounding
parenchyma associated with conspicuous interstitial
growth and inflammatory cell infiltration. The patho-
logical findings of IPMN were not detected. The left
renal pelvic tumor was invasive urothelial carcinoma.
Discussion
Undifferentiated carcinoma is a subtype of pancreatic
ductal carcinoma that exhibits sarcomatous proliferation
of severe mononuclear tumor cells and multinuclear
giant cells. It accounts for 2–7% of all pancreatic cancers
and frequently occurs in older men [2]. The favorite sites
for this tumor are the pancreatic body and tail. It is
classified into giant cell, pleomorphic cell, and spindle
cell types in accordance with the cellular morphology,
but they are often mixed [2, 3]. Abdominal pain, back
pain, weight loss, fever, anorexia, and jaundice can be the
initial symptoms [2]. About half of the patients show
elevation of WBC count and C-reactive protein (CRP)
for G-CSF production, and about 60% of the patients
show elevation of CA19-9 [4]. Since the tumor is gener-
Fig. 2. A, B MRCP (A original coronal 3D-MRCP; B 3D-
MRCP MIP) images show a papillary mass with low signal
intensity in the pancreatic body (arrows). Main pancreatic duct
dilatation is observed in the body and tail, but not in the
downstream of the mass.
Fig. 3. 18-F FDG delayed PET/CT image shows uptake of
FDG in accord with the papillary mass in the pancreatic body
(arrow).
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ally large at onset, and many cases have wide-spread
hematogenous metastasis and lymphogenous metastasis,
the prognosis is extremely unfavorable. On imaging,
undifferentiated carcinoma typically shows heteroge-
neous and dense contrast enhancement that are superior
in the peripheral zone and poor contrast enhancement in
the center owing to hemorrhage or necrosis [5]
To the best of our knowledge, 13 cases of undiffer-
entiated carcinoma with intraductal tumor growth into
the main pancreatic duct have been reported to date [6–
18]. Most cases were greater in size, and mainly showed
mass formation in the pancreatic parenchyma with
intraductal tumor growth into part of the main pancre-
atic duct [6–16]. However, Tezuka et al. reported the first
case of undifferentiated carcinoma of the pancreas in situ
within the main pancreatic duct [17] and a case report by
Bergmann et al. showed 8 mm in the largest diameter
pathologically [18]. When it comes to the case with
detection in cross-section images, our case is the smallest
in size in undifferentiated carcinoma with intraductal
tumor growth into the main pancreatic duct.
Although the debate on the histogenesis of the tumor
has been controversial, Bergmann et al. provided the
evidence for a ductal origin of the tumor histopatho-
logically [18]. Furthermore, Tezuka et al. reported the
first case of undifferentiated carcinoma of the pancreas
in situ within the main pancreatic duct, without evidence
of invasion beyond the pancreatic duct [17]. In our case,
the entire epithelium of the main pancreatic duct was
substituted by atypical cells, but the papillate region of
the tumor into the main pancreatic duct and the inter-
stitial infiltrate of the tumor were small. This finding
would support the origin of epithelial cells, not mesen-
chymal cells or stem cells. Additionally, some patholog-
ical reports have indicated that undifferentiated
carcinoma in the early stage shows intraductal growth
Fig. 4. A Loupe findings show that the tumor (arrow) pro-
trudes into the downstream edge of the dilatated main pan-
creatic duct lumen in the pancreatic body (asterisk). The
maximum diameter of the papillate region of the tumor is
8 mm and the region of interstitial infiltrate is 7 mm. B H&E
staining with low magnification shows the tumor invasion to
the surrounding parenchyma and conspicuous interstitial
growth with inflammatory cell infiltration. C H&E staining with
high magnification shows highly atypical tumor cells with
abundant scattered polymorphic structures. D The tumor cells
show positive staining for G-CSF.
Y. Kawai et al.: A case of undifferentiated carcinoma of the pancreas 469
into the main pancreatic duct [6], and our radiological
images capture the pathological features of the papillate
region of the tumor in the early stage, however, the re-
gion of interstitial infiltrate cannot be detected.
IPMN and ITPN (intraductal tubulopapillary neo-
plasm) are categorized as intraductal pancreatic tumors,
and are representative of pancreatic tumors with intra-
ductal tumor growth into the main pancreatic duct [1].
Some cases of them occur multiply in the main pancre-
atic duct and the dilatation of the duct is prominent and
diffuse [19, 20]. On the other hand, undifferentiated
carcinoma mostly occurs solitary in the previous report
and our case [6–18]. Acinar cell carcinoma and neuro-
endocrine tumor with intraductal tumor growth are also
reported as rare cases [21–23]. They typically show high
contrast enhancement in early phase on dynamic study,
which can differentiate from undifferentiated carcinoma.
Additionally, elevation of WBC count and CRP level can
help the diagnosis of undifferentiated carcinoma [4].
However, in the cases with lack of these characteristics,
differential diagnosis from early undifferentiated carci-
noma would be difficult.
Since early undifferentiated carcinoma of the pan-
creas can resemble those of main-duct IPMN in cross-
sectional images, we have to consider undifferentiated
carcinoma in the differential diagnosis of the solitary and
papillary mass with low contrast enhancement in early
phase in the main pancreatic duct.
Conclusions
We report a rare case of undifferentiated carcinoma of
the pancreas mimicking main-duct IPMN. We have to
consider undifferentiated carcinoma in the differential
diagnosis of the solitary and papillary mass with low
contrast enhancement in early phase in the main pan-
creatic duct.
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